1 |
CDK4
| [3] Tight junction Tight junction, T cell receptor signaling pathway, Viral carcinogenesis | D10688
D10688
|
Abemaciclib
| [1] 34 34 |
2 |
MAPK14
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
3 |
MAPK14
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
4 |
CSF2
| [3] T cell receptor signaling pathway T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer | D11343
D11343
|
Otilimab
| [1] 46 46 |
5 |
CTLA4
| [1] T cell receptor signaling pathway T cell receptor signaling pathway | D04603
D04603
|
Ipilimumab
| [1] 159 159 |
6 |
CTLA4
| [1] T cell receptor signaling pathway T cell receptor signaling pathway | D06657
D06657
|
Tremelimumab
| [1] 96 96 |
7 |
FYN
| [2] T cell receptor signaling pathway T cell receptor signaling pathway, Viral myocarditis | D03658
D03658
|
Dasatinib
| [2] 51 51, 85 |
8 |
FYN
| [2] T cell receptor signaling pathway T cell receptor signaling pathway, Viral myocarditis | D06414
D06414
|
Dasatinib
| [2] 51 51, 85 |
9 |
IFNG
| [7] TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D04242
D04242
|
Fontolizumab
| [1] 46 46 |
10 |
IFNG
| [7] TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D11120
D11120
|
Emapalumab
| [3] 49 49, 65, 107 |
11 |
IL4
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D03117
D03117
|
Binetrakin
| [1] 46 46 |
12 |
IL5
| [2] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, T cell receptor signaling pathway | D04923
D04923
|
Mepolizumab
| [4] 44 44, 45, 98, 162 |
13 |
IL5
| [2] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, T cell receptor signaling pathway | D08985
D08985
|
Reslizumab
| [2] 44 44, 98 |
14 |
IL10
| [5] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, T cell receptor signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
15 |
LCK
| [4] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection | D03658
D03658
|
Dasatinib
| [2] 51 51, 85 |
16 |
LCK
| [4] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection | D06414
D06414
|
Dasatinib
| [2] 51 51, 85 |
17 |
NFKB1
| [10] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D01146
D01146
|
Iguratimod
| [5] 46 46, 51, 53, 271, 300 |
18 |
PDCD1
| [1] T cell receptor signaling pathway T cell receptor signaling pathway | D10316
D10316
|
Nivolumab
| [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 |
19 |
PDCD1
| [1] T cell receptor signaling pathway T cell receptor signaling pathway | D10574
D10574
|
Pembrolizumab
| [2] 25 25, 285 |
20 |
PIK3CA
| [8] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11011
D11011
|
Alpelisib
| [1] 138 138 |
21 |
PIK3CA
| [8] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
22 |
PIK3CB
| [8] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
23 |
PIK3CD
| [8] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
24 |
PIK3CD
| [8] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11437
D11437
|
Parsaclisib
| [3] 35 35, 53, 61 |
25 |
PPP3CA
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00107
D00107
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
26 |
PPP3CA
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00184
D00184
|
Cyclosporine
| [44] 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
27 |
PPP3CA
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D05480
D05480
|
Pimecrolimus
| [1] 160 160 |
28 |
PPP3CA
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D08556
D08556
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
29 |
PPP3CA
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D09033
D09033
|
Voclosporin
| [2] 49 49, 222 |
30 |
PPP3CB
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00107
D00107
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
31 |
PPP3CB
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00184
D00184
|
Cyclosporine
| [44] 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
32 |
PPP3CB
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D05480
D05480
|
Pimecrolimus
| [1] 160 160 |
33 |
PPP3CB
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D08556
D08556
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
34 |
PPP3CB
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D09033
D09033
|
Voclosporin
| [2] 49 49, 222 |
35 |
PPP3CC
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00107
D00107
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
36 |
PPP3CC
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00184
D00184
|
Cyclosporine
| [44] 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
37 |
PPP3CC
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D05480
D05480
|
Pimecrolimus
| [1] 160 160 |
38 |
PPP3CC
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D08556
D08556
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
39 |
PPP3CC
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D09033
D09033
|
Voclosporin
| [2] 49 49, 222 |
40 |
PPP3R1
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00107
D00107
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
41 |
PPP3R1
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00184
D00184
|
Cyclosporine
| [44] 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
42 |
PPP3R1
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D05480
D05480
|
Pimecrolimus
| [1] 160 160 |
43 |
PPP3R1
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D08556
D08556
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
44 |
PPP3R1
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D09033
D09033
|
Voclosporin
| [2] 49 49, 222 |
45 |
PPP3R2
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00107
D00107
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
46 |
PPP3R2
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D00184
D00184
|
Cyclosporine
| [44] 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
47 |
PPP3R2
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D05480
D05480
|
Pimecrolimus
| [1] 160 160 |
48 |
PPP3R2
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D08556
D08556
|
Tacrolimus
| [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
49 |
PPP3R2
| [6] Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Tuberculosis | D09033
D09033
|
Voclosporin
| [2] 49 49, 222 |
50 |
PRKCQ
| [4] Vascular smooth muscle contraction Vascular smooth muscle contraction, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D09671
D09671
|
Sotrastaurin
| [1] 97 97 |
51 |
MAPK11
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
52 |
MAPK11
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
53 |
MAPK13
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
54 |
MAPK13
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
55 |
MAP2K1
| [8] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
56 |
MAP2K1
| [8] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
57 |
MAP2K1
| [8] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
58 |
MAP2K1
| [8] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
59 |
MAP2K1
| [8] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D11675
D11675
|
Mirdametinib
| [1] 34 34 |
60 |
MAP2K2
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
61 |
MAP2K2
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
62 |
MAP2K2
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
63 |
MAP2K2
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
64 |
MAP2K2
| [7] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer | D11675
D11675
|
Mirdametinib
| [1] 34 34 |
65 |
RAF1
| [5] Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Tuberculosis | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
66 |
RELA
| [10] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D12181
D12181
|
Edasalonexent
| [1] 113 113 |
67 |
MAPK12
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
68 |
MAPK12
| [10] VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
69 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00742
D00742
|
Etanercept
| [16] 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
70 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00754
D00754
|
Thalidomide
| [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
71 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
72 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02597
D02597
|
Adalimumab
| [17] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
73 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02598
D02598
|
Infliximab
| [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
74 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D03441
D03441
|
Certolizumab pegol
| [8] 37 37, 46, 49, 96, 97, 107, 226, 271 |
75 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04358
D04358
|
Golimumab
| [8] 46 46, 56, 84, 96, 97, 107, 270, 271 |
76 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04687
D04687
|
Lenalidomide
| [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
77 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D05393
D05393
|
Pegsunercept
| [1] 46 46 |
78 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D08976
D08976
|
Pomalidomide
| [5] 28 28, 51, 85, 227, 331 |
79 |
TNF
| [10] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D09944
D09944
|
Ozoralizumab
| [1] 46 46 |
80 |
CD3D
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D06314
D06314
|
Visilizumab
| [2] 96 96, 97 |
81 |
CD3D
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D08959
D08959
|
Otelixizumab
| [1] 46 46 |
82 |
CD3E
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D06314
D06314
|
Visilizumab
| [2] 96 96, 97 |
83 |
CD3E
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D08959
D08959
|
Otelixizumab
| [1] 46 46 |
84 |
CD3E
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D11463
D11463
|
Mosunetuzumab
| [1] 49 49 |
85 |
CD3G
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D06314
D06314
|
Visilizumab
| [2] 96 96, 97 |
86 |
CD3G
| [3] Th1 and Th2 cell differentiation Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D08959
D08959
|
Otelixizumab
| [1] 46 46 |
87 |
CD4
| [6] Viral life cycle - HIV-1 Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection | D06356
D06356
|
Zanolimumab
| [1] 46 46 |
88 |
CD40LG
| [3] T cell receptor signaling pathway T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis | D06193
D06193
|
Toralizumab
| [1] 63 63 |